日豐股份(002953.SZ)與中山西區辦事處簽訂戰略合作框架協議
格隆匯8月11日丨日豐股份(002953.SZ)公佈,2020年8月11日,經友好協商,公司與中山市人民政府西區辦事處(簡稱“中山西區辦事處”)簽署了《戰略合作框架協議》,為日豐股份提供項目建設支持。
雙方將基於各自的資源優勢和未來發展戰略,把握新時代,抓住新機遇,將在新基建配套、電線電纜研發製造及上下游配套、進出口業務等方面開展合作,充分發揮日豐股份產業、資本、科技的優勢和中山區位環境、產業配套的優勢,積極推動日豐股份發展壯大、引入日豐股份上下游供應鏈企業進駐中山,通過產業基地的建設,實現產業聚集、人才聚集、技術聚集和資本聚集,對中山的城市發展建設、產業升級和經濟發展做出貢獻。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.